Tertiary Lymphoid Structures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medical AI company Lunit has announced a groundbreaking collaborative study, to be presented at the 2023 World Conference on Lung Cancer (WCLC 2023), demonstrating the potential of AI-powered Tertiary Lymphoid Structures (TLS) analysis in predicting lung cancer treatment outcomes. Co-led by Lunit and esteemed medical institutions, the study demonstrates that TLS presence is strongly linked with improved overall survival in non-small cell lung cancer (NSCLC) patients.

The Scientific Advisory Board (SAB) combines the expertise of renowned scientific and international key-opinion leaders in the fields of immunology, immuno-oncology, inflammation and immunotherapy.

09.06.2022 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announces the appointment of six leading international experts to its newly formed Scientific Advisory Board (SAB) to guide the Company in its next phases ... Seite 1